Is maximal acid output useful in identifying relapsing duodenal ulcer patients?

J Clin Gastroenterol. 1985 Oct;7(5):375-8. doi: 10.1097/00004836-198510000-00001.

Abstract

In a group of 94 duodenal ulcer patients consecutively studied and followed-up for 1 year, subjects with maximal acid output (M.A.O.) above 60 mmol/hour (mostly heavy-smoking men), were found to relapse more frequently than those with lower M.A.O. values (72.2% versus 27.6%; p less than 0.0005). A significantly higher relapse rate was also detected in patients treated with maintenance dosages of effective antisecretory drugs (cimetidine, ranitidine, pirenzepine) and presenting M.A.O. over 60 mmol/hour. It is yet to be established whether an alternative therapeutic regime may prove effective in preventing ulcer recurrence in patients with gastric hypersecretion.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Benzodiazepinones / therapeutic use
  • Cimetidine / therapeutic use
  • Duodenal Ulcer / diagnosis*
  • Female
  • Follow-Up Studies
  • Gastric Acid / metabolism*
  • Humans
  • Male
  • Middle Aged
  • Pirenzepine
  • Ranitidine / therapeutic use
  • Recurrence
  • Smoking

Substances

  • Benzodiazepinones
  • Pirenzepine
  • Cimetidine
  • Ranitidine